BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
55 results:

  • 1. Surgical Management of Germline Gastrointestinal Stromal Tumor.
    Kwak HV; Tardy KJ; Allbee A; Stashek K; DeMatteo RP
    Ann Surg Oncol; 2023 Aug; 30(8):4966-4974. PubMed ID: 37115371
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
    Sokolova A; Johnstone KJ; McCart Reed AE; Simpson PT; Lakhani SR
    Histopathology; 2023 Jan; 82(1):70-82. PubMed ID: 36468211
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma.
    Augustin JE; Soussan P; Bass AJ
    Ann Oncol; 2022 Nov; 33(11):1134-1148. PubMed ID: 35963482
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
    Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
    JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
    Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
    Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer genetics and breast cancer.
    Huber-Keener KJ
    Best Pract Res Clin Obstet Gynaecol; 2022 Jun; 82():3-11. PubMed ID: 35272929
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
    Chen H; Xue L; Liu L; Li P
    J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gastrointestinal stromal tumours.
    Blay JY; Kang YK; Nishida T; von Mehren M
    Nat Rev Dis Primers; 2021 Mar; 7(1):22. PubMed ID: 33737510
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]    [Full Text] [Related]  

  • 10. A Case of Duodenal Neuroendocrine Tumor Accompanied by Gastrointestinal Stromal Tumors in Type 1 Neurofibromatosis Complicated by Life-Threatening Vascular Lesions.
    Makita N; Kayahara M; Kano S; Munemoto M; Yagi Y; Onishi I; Kawashima A
    Am J Case Rep; 2021 Jan; 22():e927562. PubMed ID: 33424018
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.
    Sun P; Li Y; Chao X; Li J; Luo R; Li M; He J
    BMC Cancer; 2020 Oct; 20(1):994. PubMed ID: 33054725
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological and Molecular Differences Between gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
    Jung H; Bae GE; Kim HM; Kim HS
    Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1.
    Balmer JC; Mikhaylov Y; Lewin DN; Mahvi DM; Ramsay Camp E
    Am Surg; 2021 Jan; 87(1):128-130. PubMed ID: 32856931
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Wild-type gastroinestinal stromal tumors].
    Djerouni M; Dumont SN
    Bull Cancer; 2020 Apr; 107(4):499-505. PubMed ID: 32063345
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Novel circular RNA circnf1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16.
    Wang Z; Ma K; Pitts S; Cheng Y; Liu X; Ke X; Kovaka S; Ashktorab H; Smoot DT; Schatz M; Wang Z; Meltzer SJ
    Endocr Relat Cancer; 2019 Mar; 26(3):265-277. PubMed ID: 30576282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
    Wang DS; Liu ZX; Lu YX; Bao H; Wu X; Zeng ZL; Liu Z; Zhao Q; He CY; Lu JH; Wang ZQ; Qiu MZ; Wang F; Wang FH; Li YH; Wang XN; Xie D; Jia WH; Shao YW; Xu RH
    Gut; 2019 Jul; 68(7):1152-1161. PubMed ID: 30269082
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pathogenic Germline Variants in 10,389 Adult cancers.
    Huang KL; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N; Scott AD; Krassowski M; Cherniack AD; Houlahan KE; Jayasinghe R; Wang LB; Zhou DC; Liu D; Cao S; Kim YW; Koire A; McMichael JF; Hucthagowder V; Kim TB; Hahn A; Wang C; McLellan MD; Al-Mulla F; Johnson KJ; ; Lichtarge O; Boutros PC; Raphael B; Lazar AJ; Zhang W; Wendl MC; Govindan R; Jain S; Wheeler D; Kulkarni S; Dipersio JF; Reimand J; Meric-Bernstam F; Chen K; Shmulevich I; Plon SE; Chen F; Ding L
    Cell; 2018 Apr; 173(2):355-370.e14. PubMed ID: 29625052
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
    Müller V; Clemens M; Jassem J; Al-Sakaff N; Auclair P; Nüesch E; Holloway D; Shing M; Bang YJ
    BMC Cancer; 2018 Mar; 18(1):295. PubMed ID: 29544445
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.